Analytics

Experts discuss factors that can affect the outcome of an ADME study, signs that a drug compound shows promise, red flags, and key parameters to determine safety and efficacy.

Single-use systems can benefit from standardized risk assessment and analysis protocols, which can facilitate the way in which processing equipment components are compared.

With the evolution of scalability of peripheral blood protein glycosylation, research has expanded for new biomarkers.

An early drug candidate screening strategy should incorporate clear targets to lessen late-stage failure.

OGT has launched the SureSeq Myeloid Plus panel and OGT Universal NGS Complete Workflow.

Recent technological advancements may have put cleanroom monitoring into a state of flux.

Production of viral vectors requires a holistic view of the product, including its manufacturing process and its ultimate end use.

This article introduces a control chart technique using F statistic for continued process verification of oral solid dosage forms.

Standardized risk assessment and analysis protocols facilitate the comparison of processing equipment components.

Using an orthogonal approach to lipid nanoparticle analysis can increase the odds of project success.

A combination of eye imaging techniques and adaptive optics has revealed key details of choroideremia.

The dedicated solid-state research and development suite is designed to promote discovery of novel polymorph, salt, and cocrystal forms.

Avance Clinical’s acquisition of C3 Research Associates expands its CRO services to North America.

Innovation is driven through a strong digital backbone.

An integrated approach to the data lifecycle is key to successful digital transformation.

It is argued that orthogonal quantitative methods can be used to establish primary working standards. An example details how to calculate the expanded measurement uncertainty (U) for the certified assay value by considering two orthogonal assay methods.

Cleanroom monitoring may be in a state of flux after many recent technological advancements.

It is important to understand regulatory requirements and study challenges to develop and validate the appropriate methods for a bioanalytical study program at the clinical stage.

Roche’s Digital LightCycler System is designed to aid in diagnostics for cancer, genetic disease, and infection.

CYTENA’s B.SIGHT cell dispenser is designed to streamline single-cell isolation in microbiology research.

The Faustovirus Capping Enzyme launched by New England Biolabs is designed to increase capping efficiency and scalability of mRNA manufacturing workflows.

Guest contributor B.S. Sathya Durga discusses the importance of modernizing India's pharmaceutical manufacturing industry.

Synthego has launched new engineered cell libraries to validate targets for quicker drug discovery timelines.

A comprehensive understanding of potential material change can mitigate its impact on patient safety.

Innovations in single-cell analytics have advanced the progression of cell biology research, which has brought new understanding of disease mechanisms.

Automated finished product inspection has been widely adopted in the bio/pharmaceutical industry.

Successful digital transformation in biopharma requires an integrated approach to the data lifecycle.

Screening for apparent total nitrosamine content with a thermal energy analyzer offers a rapid way of identifying contaminated drug products.

PerkinElmer’s GC 2400 Platform is designed to perform various sampling tasks related to gas chromatography and headspace sampling.

Shimadzu’s new ultra-high performance liquid chromatography system is designed to solve common problems in biopharma analysis.